
Hunting for New Drugs with AI
The pharmaceutical industry is in a drug-discovery slump. How much can AI help?
David H. Freedman is a journalist who has been covering science, business and technology for more than 30 years. Credit: Nick Higgins
The pharmaceutical industry is in a drug-discovery slump. How much can AI help?
Most cancer patients never get into lifesaving drug trials because of barriers at community hospitals
Science has identified four steps to losing weight that can improve the odds of success
Proponents of genetically modified crops say the technology is the only way to feed a warming, increasingly populous world. Critics say we tamper with nature at our peril. Who is right?
Is NASA's Space Launch System a flying piece of congressional pork or our best shot at getting humans to deep space?
Proponents of genetically modified crops say the technology is the only way to feed a warming, increasingly populous world. Critics say we tamper with nature at our peril. Who is right?
Impulsivity arises from a tendency to want small imminent rewards more than big future benefits. How can we correct our skewed values to care for our future selves?
Despite the lessons of the 2008 collapse, Wall Street is betting our future on flimsy science
Financial-risk models got us in trouble before the 2008 crash, and they're almost sure to get us in trouble again
Although science has revealed a lot about metabolic processes that influence our weight, the key to success may lie elsewhere
Why NASA's plan to get out of the manned spaceflight business may (finally) make space travel routine
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account